Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,89 USD | +4,42% | +11,18% | -83,83% |
Attività
Numero di dipendenti: 14
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01/12/20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/08/22 |
Mark Densel
PRN | Corporate Officer/Principal | - | 01/11/18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 26/09/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Director/Board Member | 54 | 25/08/21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11/09/23 |
Brian Gallagher
CHM | Chairman | 54 | 01/01/20 |
Barbara Klencke
BRD | Director/Board Member | 66 | 01/11/21 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 25/08/21 |
Director/Board Member | 51 | 15/02/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 3 699 309 | 3 553 586 ( 96,06 %) | 12 000 ( 0,3244 %) | 96,06 % |
Coordinate società
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-83,83% | 6,97 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione EFTR
- Società eFFECTOR Therapeutics, Inc.